| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7305354afee302fc308a2f279c007916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30cd0f36a6c650e575dcea950681545b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61fd90d8d380e65c604cfccfb3a25a0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b1f1f12fe65c484927c6d34bbdd7587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fd59c423663682f32eeae43f7f9d408 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-195 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2001-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a14a5e21279f7c4ffe9630dde4b7c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c182f446111bc264830f852b206ed88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eeb7ec253f32ba51608e91fbd61c574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ef8266e55c3fc5753b8bd886aebf3e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a181797d86e341b42f779f498b381f |
| publicationDate |
2002-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0230464-A1 |
| titleOfInvention |
Novel drugs for liver diseases |
| abstract |
Preventives and/or remedies for liver diseases containing as the active ingredient monocyte chemoattractant protein-1 (MCP-1) function inhibitors. Administration of the MCP-1 function inhibitors exerts effects of preventing and/or treating liver diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1447095-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7666413-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10166293-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8961964-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7476381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004062688-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8142776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1447095-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318161-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034940-B2 |
| priorityDate |
2000-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |